scholarly journals Clinico-pathological review of ciliated muconodular papillary tumour of lung

2018 ◽  
Vol 4 (2) ◽  
pp. 150-152
Author(s):  
Dr. Sabah Nayef Nemri ◽  
◽  
Dr. Nazima Haider ◽  
Dr. Sohaila Fatima ◽  
◽  
...  
Keyword(s):  
Papillary Tumour ◽  
Pathological Review

Olfactory neuroblastoma: a multi centre clinical and pathological review

2016 ◽  
Author(s):  
Karen Young ◽  
Nara Orban ◽  
Peter Clarke ◽  
Ann Sandison ◽  
Catherine Gilkes ◽  
...  
Keyword(s):  
Olfactory Neuroblastoma ◽  
Pathological Review

scholarly journals EPEN-24. SIOP EPENDYMOMA II: CENTRAL EPENDYMOMA MANAGEMENT ADVISORY GROUP – THE UK EXPERIENCE

2020 ◽  
Vol 22 (Supplement_3) ◽  
pp. iii312-iii312
Author(s):  
Donald C Macarthur ◽  
Conor Mallucci ◽  
Ian Kamaly-Asl ◽  
John Goodden ◽  
Lisa C D Storer ◽  
...  
Keyword(s):  
Survival Rates ◽  
Target Volume ◽  
Advisory Group ◽  
Subtotal Resection ◽  
Str Analysis ◽  
Oncological Treatment ◽  
Beneficial Effects ◽  
Number Of Patients ◽  
Pathological Review ◽  
The Uk

Abstract Paediatric Ependymoma is the second most common malignant brain tumour of childhood with approximately 50% of cases recurring. It has been described as a “surgical” disease since patients who have undergone a gross total surgical resection (GTR) have a better prognosis than those who have a subtotal resection (STR). Analysis of the UKCCSG/SIOP 1992 04 clinical trial has shown that only 49% of cases had a GTR, with 5-year survival rates for STR of 22–47% and GTR of 67–80%. As part of the SIOP II Ependymoma trial the UK established a panel of experts in the treatment of Ependymoma from Neuro-oncology, Neuro-radiology and Neuro-surgery. Meeting weekly, cases are discussed to provide a consensus on radiological review, ensuring central pathological review, trial stratification and whether further surgery should be advocated on any particular case. Evaluation of the first 68 UK patients has shown a GTR in 47/68 (69%) of patients and STR in 21/68 (31%) of patients. Following discussion at EMAG it was felt that 9/21 (43%) STR patients could be offered early second look surgery. Following this 2nd look surgery the number of cases with a GTR increased to 56/68 (82%). There has been a clear increase in the number of patients for whom a GTR has been achieved following discussion at EMAG and prior to them moving forwards with their oncological treatment. This can only have beneficial effects in decreasing their risk of tumour recurrence or CSF dissemination and also in reducing the target volume for radiotherapy.

GEOGRAPHIC TONGUE: A CUNICO-PATHOLOGICAL REVIEW

1981 ◽  
Vol 22 (2) ◽  
pp. 75-79 ◽  
Author(s):  
Roitin Marks ◽  
Bryan G. Raddin
Keyword(s):  
Pathological Review

scholarly journals Prediction of Patients with Acute Cholecystitis Requiring Emergent Cholecystectomy: A Simple Score

2010 ◽  
Vol 2010 ◽  
pp. 1-5 ◽  
Author(s):  
Wael N. Yacoub ◽  
Mikael Petrosyan ◽  
Indu Sehgal ◽  
Yanling Ma ◽  
Parakrama Chandrasoma ◽  
...  
Keyword(s):  
Heart Rate ◽  
Logistic Regression ◽  
Acute Cholecystitis ◽  
High Probability ◽  
Acute Inflammation ◽  
Gallbladder Wall ◽  
Cutoff Score ◽  
Gangrenous Cholecystitis ◽  
Pathological Review ◽  
Low Probability

The objective was to develop a score, to stratify patients with acute cholecystitis into high, intermediate, or low probability of gangrenous cholecystitis. The probability of gangrenous cholecystitis (score) was derived from a logistic regression of a clinical and pathological review of 245 patients undergoing urgent cholecystectomy. Sixty-eight patients had gangrenous inflammation, 132 acute, and 45 no inflammation. The score comprised of: age > 45 years (1 point), heart rate > 90 beats/min (1 point), male (2 points), Leucocytosis > 13,000/mm3(1.5 points), and ultrasound gallbladder wall thickness>4.5 mm (1 point). The prevalence of gangrenous cholecystitis was 13% in the low-probability (0–2 points), 33% in the intermediate-probability (2–4.5 points), and 87% in the high probability category (>4.5 points). A cutoff score of 2 identified 31 (69%) patients with no acute inflammation (PPV 90%). This scoring system can prioritize patients for emergent cholecystectomy based on their expected pathology.

scholarly journals Revisiting the role of the pathological grading in pediatric adrenal cortical tumors: results from a national cohort study with pathological review

2018 ◽  
Vol 32 (4) ◽  
pp. 546-559 ◽  
Author(s):  
Cécile Picard ◽  
Daniel Orbach ◽  
Matthieu Carton ◽  
Laurence Brugieres ◽  
Karine Renaudin ◽  
...  
Keyword(s):  
Cohort Study ◽  
Pathological Review ◽  
National Cohort

scholarly journals PSEUDO PAPILLARY TUMOUR OF PANCREAS

2009 ◽  
Vol 16 (04) ◽  
pp. 609-610
Author(s):  
QURATULAIN SOOMRO ◽  
Hafeez Soomro ◽  
KHAN MUHAMMAD ◽  
Sardar Khatoon ◽  
ABDUL SAMAD SHAIKH ◽  
...  
Keyword(s):  
Excisional Biopsy ◽  
Malignant Potential ◽  
Definitive Treatment ◽  
Low Grade ◽  
Young Females ◽  
Invasive Tumour ◽  
Papillary Tumour ◽  
Pancreatic Tumour ◽  
Low Malignant Potential

During 05 years period from January 2003 to December 2007,45 cases of Ca. Pancreas were reported to LINAR and only onecase of Pseudo Papillary Tumour of Pancreas is registered. It is a rare, low malignant potential pancreatic tumour. It has unknown pathogenesisand found in young females. We report a case of 24 years old female, who presented with pain in abdomen and low grade fever of 07 monthsduration. Lepratomy and excisional biopsy was done. H/P came as Pseudo Papillary Tumour of Pancreas. At presentation no any L.N. werefound enlarged. Like other malignant pancreatic tumours, this neoplasm does not metastasize. Its definitive treatment is complete surgicalremoval, no any role of chemotherapy because it doesn't metastasized, limited role of radiotherapy in local invasive tumour or in residual mass.

scholarly journals Prognostic impact of pelvic and para-aortic lymphadenectomy on clinically-apparent stage I primary mucinous epithelial ovarian carcinoma: a multi-institutional study with propensity score-weighted analysis

2019 ◽  
Author(s):  
Masato Yoshihara ◽  
Hiroaki Kajiyama ◽  
Satoshi Tamauchi ◽  
Shohei Iyoshi ◽  
Akira Yokoi ◽  
...  
Keyword(s):  
Lymph Node ◽  
Propensity Score ◽  
Ovarian Carcinoma ◽  
Pelvic Lymphadenectomy ◽  
Epithelial Ovarian Carcinoma ◽  
Stage I ◽  
Therapeutic Effects ◽  
Prognostic Impact ◽  
Pathological Review ◽  
Using Data

Abstract Background The exact impact of full-staging lymphadenectomy on patients with primary mucinous epithelial ovarian carcinoma confined to the ovary is still unclear. In this study, we investigated the prognostic impact of lymphadenectomy covering both pelvic and para-aortic lymph nodes in patients with clinically-apparent stage I mucinous epithelial ovarian carcinoma, using data from multi-institutions under a central pathological review system and analyses with a propensity score-based method. Methods We conducted a regional multi-institutional retrospective study between 1986 and 2017. Among 4730 patients with malignant ovarian tumors, a total of 186 women with mucinous epithelial ovarian carcinoma were eligible. We evaluated differences in survival outcomes between patients with both pelvic and para-aortic lymphadenectomy and those with only pelvic lymphadenectomy and/or clinical lymph node evaluation. To analyze the therapeutic effects, the baseline imbalance between patients with both pelvic and para-aortic lymphadenectomy and others was adjusted with an inverse probability of treatment weighting using propensity score involving independent clinical variables. Results Fifty-five patients received both pelvic and para-aortic lymphadenectomy. With PS-based adjustment, both pelvic and para-aortic lymphadenectomy did not have additive effects regarding overall survival (P = 0.696) and recurrence-free survival (P = 0.978). Multivariate analysis similarly showed no significant impact of both pelvic and para-aortic lymphadenectomy on their prognosis. Conclusions The effect of pelvic and para-aortic lymphadenectomy is limited for clinically-apparent stage I primary mucinous epithelial ovarian carcinoma as long as full peritoneal and clinical lymph node evaluations are conducted. The results of this study should be used as the basis for additional studies, including prospective trials.

Sign in / Sign up

Export Citation Format

Share Document